Thus, aberrant retention of USP1 molecule on DNA caused by combined SPRTN and USP1 catalytic inhibition may be effective in further enhancing cytotoxicity of cisplatin and other chemotherapeutics in a variety of cancer cells. The gene discussed is USP1; the disease is cancer.